Doctor Davide Stolfo

Doctor Davide Stolfo

Giuliano Isontina University Health Authority, Trieste (Italy)

Member of:

Davide Stolfo is an Italian cardiologist working in the CCU of the Cattinara Hospital in Trieste (Italy). He is part of the “Outpatient Clinic for HF and genetic cardiomyopaties” and coordinates the activity of the “PH Outpatient Clinic”. He is also part of the ECMO team and member of the roundtable of his region for advanced heart failure – patients selection for MCS – ECLS. He graduated at the University of Trieste (2008) and completed Cardiology residency in Trieste in 2014. He also had clinical experience as clinical and research fellow at the Royal Brompton Hospital (London, UK), Harefield Hospital (London, UK) and Stanford University (Palo Alto, CA – USA). In 2017 he got the title of HF specialist from the University of Zurich, the HFA-ESC. He completed his PhD at the Karolinska Institutet (Stockholm, Sweden) on June 2022. He has published/presented several articles on top peer reviewed journals as first author/coauthor and in international congresses.

Presentations Articles

Real-world use of sodium-glucose co-transporter 2 inhibitors in patients with heart failure and reduced ejection fraction: data from the Swedish heart failure registry

Event: Heart Failure 2023

Topic: Pharmacotherapy

Session: Pharmacotherapy

Access

How to maintain optimised drug therapy in the multimorbid patient

Event: Heart Failure 2023

Topic: Cardiovascular Nursing and Allied Professions

Session: Care for the patient with complex HF- beyond drugs uptitration

Access

Burden and predictors of non-cardiovascular mortality and morbidity events in advanced heart failure

Event: Heart Failure 2023

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic heart failure - epidemiology, prognosis, outcome 3

Access

Persistent high burden of heart failure across the ejection fraction spectrum: data from the Swedish heart failure registry

Event: Heart Failure 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Heart failure patient profile and outcome 1

Access

Use of heart failure evidence-based therapy across age strata: data from the Swedish Heart Failure Registry

Event: Heart Failure 2021

Topic: Pharmacotherapy

Session: Chronic Heart Failure - Treatment 2

Access

Impact on clinical outcomes of right ventricular response to percutaneous correction of secondary mitral regurgitation

Event: Heart Failure 2021

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: ePoster session

Access

Genetic risks for arrhythmia phenotypes in dilated cardiomyopathy

Event: ESC Congress 2019

Topic: Idiopathic Dilated Cardiomyopathy

Session: Basic Science

Access

Sex-based differences in heart failure across the ejection fraction spectrum: phenotyping, prognostic and therapeutic implications

Event: Heart Failure 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Moderated Poster Session: Everlasting questions, new answers

Access

ST-elevation myocardial infarction with reduced left ventricular ejection fraction: insights into persisting left ventricular dysfunction. A pPCI-Registry analysis.

Event: HEART FAILURE 2016

Topic: Left ventricular function

Session: Left ventricular function

Access

Genotype-phenotype correlations: association between mutation status and left ventricular reverse remodeling in idiopathic dilated cardiomyopathy

Event: HEART FAILURE 2016

Topic: Dilated cardiomyopathy

Session: Cardiomyopathy

Access

Doctor Davide Stolfo

Biography

Contributor content

Real-world use of sodium-glucose co-transporter 2 inhibitors in patients with heart failure and reduced ejection fraction: data from the Swedish heart failure registry

How to maintain optimised drug therapy in the multimorbid patient

Burden and predictors of non-cardiovascular mortality and morbidity events in advanced heart failure

Persistent high burden of heart failure across the ejection fraction spectrum: data from the Swedish heart failure registry

Use of heart failure evidence-based therapy across age strata: data from the Swedish Heart Failure Registry

Impact on clinical outcomes of right ventricular response to percutaneous correction of secondary mitral regurgitation

Genetic risks for arrhythmia phenotypes in dilated cardiomyopathy

Sex-based differences in heart failure across the ejection fraction spectrum: phenotyping, prognostic and therapeutic implications

ST-elevation myocardial infarction with reduced left ventricular ejection fraction: insights into persisting left ventricular dysfunction. A pPCI-Registry analysis.

Genotype-phenotype correlations: association between mutation status and left ventricular reverse remodeling in idiopathic dilated cardiomyopathy

ESC 365 is supported by